The biotech reset
Listen now
Description
Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in the biotech field. For full show notes, visit: https://highlightai.com/share/f4d42739-65df-42d9-a6b4-6c1327705d7a  — 📰Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess   — SPONSORS: 📝 Notion offers powerful workflow and automation templates, perfect for streamlining processes and laying the groundwork for AI-driven automation. With Notion AI, you can search across thousands of documents from various platforms, generating highly relevant analysis and content tailored just for you - try it for free at notion.com/upstreampod 🕵️‍♂️ Take your personal data back with Incogni! Use code ECON102 at the link below and get 60% off an annual plan: https://incogni.com/econ102 — LINKS: Gallup Oncology: https://www.galloponcology.com/ PureTech Health: https://www.puretechhealth.com/  — FOLLOW: https://www.linkedin.com/in/christinafarr/  https://www.linkedin.com/in/lubagreenwood/  https://www.linkedin.com/in/ashzenooz/
More Episodes
Ash Zenooz and Luba Greenwood interview Andrea Ippolito about her extensive career in healthcare spanning academia, government, and the private sector, as well as her current role as founder and CEO of SimpiFed. They discuss the intricacies of government roles, the importance of women's health,...
Published 12/04/24
Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appointments, and AI in medicine. The second half of the episode was recorded...
Published 11/16/24